[Clinical application of microencapsulated antineoplastic agents].
D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000008:administration & dosage*; D002214:Capsules; D003692:Delayed-Action Preparations; D004285:Dogs; D004621:Embolization, Therapeutic / Q000009:adverse effects / Q000379:methods*; D005260:Female; D006801:Humans; D008297:Male; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage*; D009369:Neoplasms / Q000098:blood supply / Q000628:therapy*; D001749:Urinary Bladder Neoplasms / Q000628:therapy
D000903:Antibiotics, Antineoplastic; D002214:Capsules; D003692:Delayed-Action Preparations; D008937:Mitomycins; D016685:Mitomycin